• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用治疗方法对帕金森病固有免疫反应的动力学进行建模。

Modeling the dynamics of innate immune response to Parkinson disease with therapeutic approach.

机构信息

Mathematics Department, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

Phys Biol. 2022 Aug 18;19(5). doi: 10.1088/1478-3975/ac8516.

DOI:10.1088/1478-3975/ac8516
PMID:35901788
Abstract

This paper aims to mathematically model the dynamics of Parkinson's disease with therapeutic strategies. The constructed model consists of five state variables: healthy neurons, infected neurons, extracellular-syn, active microglia, and resting microglia. The qualitative analysis of the model produced an unstable free equilibrium point and a stable endemic equilibrium point. Moreover, these results are validated by numerical experiments with different initial values. Two therapeutic interventions, reduction of extracellular-syn and reduction of inflammation induced by activated microglia in the central nervous system, are investigated. It is observed that the latter has no apparent effect in delaying the deterioration of neurons. However, treatment to reduce extracellular-syn preserves neurons and delays the onset of Parkinson's disease, whether alone or in combination with another treatment.

摘要

本文旨在通过治疗策略对帕金森病的动力学进行数学建模。所构建的模型由五个状态变量组成:健康神经元、感染神经元、细胞外突触、活性小胶质细胞和静止小胶质细胞。模型的定性分析产生了一个不稳定的自由平衡点和一个稳定的地方病平衡点。此外,这些结果通过不同初始值的数值实验进行了验证。研究了两种治疗干预措施,即减少细胞外突触和减少中枢神经系统中活性小胶质细胞引起的炎症。结果表明,后者对延缓神经元恶化没有明显效果。然而,无论单独使用还是与另一种治疗方法联合使用,减少细胞外突触的治疗方法都能保护神经元并延缓帕金森病的发作。

相似文献

1
Modeling the dynamics of innate immune response to Parkinson disease with therapeutic approach.用治疗方法对帕金森病固有免疫反应的动力学进行建模。
Phys Biol. 2022 Aug 18;19(5). doi: 10.1088/1478-3975/ac8516.
2
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.抑制JAK/STAT信号通路可预防α-突触核蛋白诱导的神经炎症和多巴胺能神经退行性变。
J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.
3
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.靶向 II 类转录激活因子可减轻帕金森病 α-突触核蛋白模型中的炎症和神经退行性变。
J Neuroinflammation. 2018 Aug 30;15(1):244. doi: 10.1186/s12974-018-1286-2.
4
Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson's Disease.中枢和外周炎症:连接帕金森病的免疫反应。
J Parkinsons Dis. 2022;12(s1):S129-S136. doi: 10.3233/JPD-223241.
5
Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.代谢型谷氨酸受体 5 抑制 α-突触核蛋白诱导的小胶质细胞炎症,从而保护帕金森病的神经毒性。
J Neuroinflammation. 2021 Jan 18;18(1):23. doi: 10.1186/s12974-021-02079-1.
6
What can trigger the onset of Parkinson's disease - A modeling study based on a compartmental model of α-synuclein transport and aggregation in neurons.什么会引发帕金森病的发作——一项基于神经元中α-突触核蛋白运输和聚集的房室模型的建模研究。
Math Biosci. 2016 Aug;278:22-9. doi: 10.1016/j.mbs.2016.05.002. Epub 2016 May 17.
7
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.先天免疫受体刺激对脑驻留细胞摄取和降解细胞外α-突触核蛋白的影响。
Exp Mol Med. 2021 Feb;53(2):281-290. doi: 10.1038/s12276-021-00562-6. Epub 2021 Feb 16.
8
Microglia in Parkinson's Disease.帕金森病中的小胶质细胞。
Adv Exp Med Biol. 2019;1175:335-353. doi: 10.1007/978-981-13-9913-8_13.
9
Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.α-突触核蛋白升高会损害固有免疫细胞的功能,并为帕金森病提供一个潜在的外周生物标志物。
PLoS One. 2013 Aug 23;8(8):e71634. doi: 10.1371/journal.pone.0071634. eCollection 2013.
10
Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.非聚集态 α-突触核蛋白在小鼠中引发的神经胶质固有免疫:野生型与帕金森病相关突变体之间的差异。
PLoS One. 2010 Oct 26;5(10):e13481. doi: 10.1371/journal.pone.0013481.

引用本文的文献

1
Quantitative systems pharmacology model of α-synuclein pathology in Parkinson's disease-like mouse for investigation of passive immunotherapy mechanisms.用于研究被动免疫疗法机制的帕金森病样小鼠 α-突触核蛋白病的定量系统药理学模型。
CPT Pharmacometrics Syst Pharmacol. 2024 Oct;13(10):1798-1809. doi: 10.1002/psp4.13223. Epub 2024 Aug 23.